logo

For the Inventor, By the Inventor

Palmyra, NJ, United States of America

Russell J Taylor, Jr

This inventor holds 9 USPTO granted patents. Top assignees: Mcneil Laboratories, Incorporated, Ncneil Laboratories, Incorporated. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Russell J Taylor, Jr. Retrieved from https://idiyas.com/inventor/russell-j-taylor-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 1.3

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:

goldMedal8 out of 45 
 
Mcneil Laboratories, Incorporated
 patents
silverMedal1 out of 1 
 
Ncneil Laboratories, Incorporated
 patent

Years Active: 1976

Loading Chart...
9 patents (USPTO):Explore Patents
1. 3985880 - 2-(R'-oxymethyl)-perimidines (1976-10-12),
2. 3980782 - Inhibition of gastric acid secretion with phenyl-substituted perimidines (1976-09-14),
3. 3966935 - Inhibition of ulcers with 2(3H)-perimidylidene-2-propanone (1976-06-29),
4. 3966933 - Inhibition of gastric acid secretion with 1-alkyl-2-R-perimidines (1976-06-29),
5. 3957993 - Inhibition of ulcers with pyrrolyl-substituted perimidines (1976-05-18),
6. 3957992 - Inhibition of gastric acid secretion with 2-pyridyl-perimidine (1976-05-18),
7. 3957991 - Inhibition of gastric acid secretion with substituted perimidines (1976-05-18),
8. 3956497 - Inhibition of gastric acid secretion with 1-dialkylamidomethyl-2-alkyl (1976-05-11),
9. 3956496 - Inhibition of gastric acid secretion with 2-(tetrahydrofuryl)perimidine (1976-05-11),

Title: The Innovative Contributions of Russell J Taylor, Jr.

Introduction

Russell J Taylor, Jr. is a notable inventor based in Palmyra, NJ (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 9 patents to his name, Taylor has made strides in developing compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are the novel 2-(R'-oxymethyl)-perimidines, which have been identified as useful antiulcer agents due to their activity as inhibitors of gastric acid secretion and ulcer formation. These compounds include derivatives where R' is selected from a group consisting of benzoyl, carbamyl, N-loweralkylcarbamyl, and N,N-diloweralkylcarbamyl. Another significant patent involves the use of 2-aryl-perimidines as inhibitors of gastric acid secretion, showcasing Taylor's focus on addressing gastrointestinal issues through innovative chemical solutions.

Career Highlights

Throughout his career, Taylor has worked with prominent companies such as McNeil Laboratories, Incorporated, where he contributed to research and development efforts in the pharmaceutical industry. His work has been instrumental in advancing the understanding and treatment of various medical conditions.

Collaborations

Taylor has collaborated with various professionals in his field, including Vasken Paragamian, enhancing the scope and impact of his research endeavors.

Conclusion

Russell J Taylor, Jr. stands out as a dedicated inventor whose work in developing antiulcer agents has the potential to improve patient outcomes. His contributions to the pharmaceutical industry reflect a commitment to innovation and excellence.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…